The team analysed data from 27,090 patients in England diagnosed with dementia between January 2000 and March 2016. The average age of the patients was 83 and 62 percent were women. They looked at the adverse events for 3,532 patients who had been prescribed Z-drugs and compared them to p...
Behavioral Therapy Helps More Than Drugs For Dementia PatientsIna Jaffe
Drugs to help dementia patients sleep better are linked to an increased risk of bone fractures, according to new research from the University of East Anglia (UEA). Researchers investigated dementia patients taking commonly-prescribed hypnotics known as “Z-drugs” (such as zolpidem, zopiclone, and ...
In a one-year period, 41 patients suffering from dementia presented to a large psychiatric hospital; four were found to have reversible etiologies. In addition, 16 elderly patients with admission diagnoses of depression were found to be ... Rabins,V Peter - 《Hosp Community Psychiatry》 被引量...
"As there are very few drugs for the management of dementia, we want to know whether a well-known, well-tolerateddrugcan be used to help patients with this particular type of dementia. "My colleagues and I are very enthusiastic about this trans-Atlantic initiative." ...
The recruited patients are receiving 265 mg ALZ-801 or placebo twice daily for 18 months. The trial started in May 2021. The primary endpoint is ADAS-Cog scores, and the secondary endpoints are scores of the Disability Assessment for Dementia, CDR-SB, and Amsterdam-iADL. The biomarkers of ...
Only a few surveys of prescribing patterns of drugs for dementia have been conducted in developing countries, while the proportion of dementia patients is expected to become higher in these regions. We aim to evaluate the utilization patterns, adverse events, and cost of antidementia drugs in a ...
The latest review of medications approved by the US Food and Drug Administration for the treatment of patients with dementia shows that even though the drugs pass muster statistically on scales that measure patients' cognitive function, they produce little if any clinically meaningful benefit (Raina ...
Should drugs be prescribed for prevention in the case of moderate or severe dementia? Introduction: Physicians often wonder about the relevance of starting or continuing medications for prevention in the context of moderate or severe dementi... M Arcand,J Roy-Petit,G Voyer,... - 《La Revue ...
(APOE4/4). The recruited patients are receiving 265 mg ALZ-801 or placebo twice daily for 18 months. The trial started in May 2021. The primary endpoint is ADAS-Cog scores, and the secondary endpoints are scores of the Disability Assessment for Dementia, CDR-SB, and Amsterdam-iADL. The ...